FDA
-
-
-
-
-
-
-
Todos Medical Announces Commercialization of Lesion and Saliva-Based MonkeyPox PCR Testing
-
-
-
-
-
-
-
Todos Medical Applauds White House Initiative on Long COVID and Announces New Tollovid® US FDA Certificate of Free Sale with Daily and Acute Dosing on the Label
-
-
-
-
-
-
-
Todos Medical Reports Second Quarter 2021 Financial Results
-
-
-
-
-
-
-
Todos Medical Receipt Notice of Allowance from USPTO for 3CL Protease Inhibitor Dietary Supplement Tollovid™
-
-
-
-
-
-
-
Todos Medical Provides Corporate Update
-
-
-
-
-
-
-
Todos Medical Announces Distribution Agreement with Adial Pharmaceuticals to Market the FDA, EUA Authorized, Assure/FaStep(R) Point-of-Care Covid-19 Antibody Tests
-
-
-
-
-
-
-
Todos Medical Ltd. (TOMDF) Reports $4.5M Contract for COVID-19 PCR Testing Equipment & Supplies with New York-based Laboratory
-
322,897 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

